CG
CTVA icon

Cynosure Group’s Corteva CTVA Stock Holding History

Cynosure Group’s Portfolio CTVA Stock Details CTVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,090
Closed -$475K – 271
2025
Q4 		$475K Buy
+7,090
New +$458K 0.05% 223

Other funds holding CTVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Cynosure Group's CTVA Position: Q1 2026 in Review

Cynosure Group sold out of Corteva (CTVA) in Q1 2026, closing a stake of 7,090 shares — an estimated $475K sold.

Cynosure Group first reported a position in CTVA in Q4 2025 and held it in 1 quarter. The position peaked at $475K in Q4 2025. 1,476 funds tracked by Wall St. Rank hold CTVA as of Q1 2026.

  • Cynosure Group reported no remaining Corteva position as of Q1 2026 after selling out during the quarter.
  • Cynosure Group sold 7,090 Corteva shares in Q1 2026, an estimated $475K.
  • Cynosure Group first reported a position in Corteva in Q4 2025 and held it in 1 quarter.
  • Cynosure Group's Corteva position peaked at $475K in Q4 2025.
  • 1,476 funds tracked by Wall St. Rank held Corteva as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.